168 related articles for article (PubMed ID: 36241993)
1. Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment.
Herrick T; Thomson KA; Shin M; Gannon S; Tsu V; de Sanjosé S
BMC Health Serv Res; 2022 Oct; 22(1):1246. PubMed ID: 36241993
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Campos NG; Castle PE; Wright TC; Kim JJ
Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
Cubie HA; Campbell C
Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
[TBL] [Abstract][Full Text] [Related]
5. HPV-based cervical cancer screening in Nicaragua: from testing to treatment.
Holme F; Maldonado F; Martinez-Granera OB; Rodriguez JM; Almendarez J; Slavkovsky R; Bansil P; Thomson KA; Jeronimo J; de Sanjose S
BMC Public Health; 2020 Apr; 20(1):495. PubMed ID: 32295562
[TBL] [Abstract][Full Text] [Related]
6. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
[TBL] [Abstract][Full Text] [Related]
7. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
[TBL] [Abstract][Full Text] [Related]
8. Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa.
Rao DW; Bayer CJ; Liu G; Chikandiwa A; Sharma M; Hathaway CL; Tan N; Mugo N; Barnabas RV
J Int AIDS Soc; 2022 Oct; 25(10):e26021. PubMed ID: 36225139
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
Campos NG; Tsu V; Jeronimo J; Njama-Meya D; Mvundura M; Kim JJ
Health Policy Plan; 2017 Sep; 32(7):956-968. PubMed ID: 28369405
[TBL] [Abstract][Full Text] [Related]
10. Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination.
Grimes DR; Corry EMA; Malagón T; O'Riain C; Franco EL; Brennan DJ
JAMA Netw Open; 2021 Jun; 4(6):e2115321. PubMed ID: 34190993
[TBL] [Abstract][Full Text] [Related]
11. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
Bruni L; Serrano B; Roura E; Alemany L; Cowan M; Herrero R; Poljak M; Murillo R; Broutet N; Riley LM; de Sanjose S
Lancet Glob Health; 2022 Aug; 10(8):e1115-e1127. PubMed ID: 35839811
[TBL] [Abstract][Full Text] [Related]
13. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
[TBL] [Abstract][Full Text] [Related]
14. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
[TBL] [Abstract][Full Text] [Related]
15. Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.
Bogale AL; Teklehaymanot T; Kassie GM; Medhin G; Ali JH; Belay NB
Cancer Control; 2022; 29():10732748221114980. PubMed ID: 35829643
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.
Vanni T; Luz PM; Grinsztejn B; Veloso VG; Foss A; Mesa-Frias M; Legood R
Int J Cancer; 2012 Jul; 131(2):E96-104. PubMed ID: 21964797
[TBL] [Abstract][Full Text] [Related]
17. Training, Supervision, and Competence Assessment of Cameroonian Health Care Providers Using HPV Self-Sampling, Triage by Visual Inspection, and Treatment by Thermal Ablation in a Single Visit.
Frund C; Kenfack B; Sormani J; Wisniak A; Fouogue JT; Tincho E; Metaxas T; Vassilakos P; Petignat P
Front Public Health; 2022; 10():875177. PubMed ID: 35419330
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive approach to costing cervical cancer prevention and control: a case study in the United Republic of Tanzania using the Cervical Cancer Prevention and Control Costing (C4P) tool.
Levin A; Yuma S; Swai E; Morgan W; Gauvreau CL; Broutet N; Yeung KHT; Hutubessy R
BMC Med; 2022 Nov; 20(1):384. PubMed ID: 36316680
[TBL] [Abstract][Full Text] [Related]
19. Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
Hall MT; Simms KT; Murray JM; Keane A; Nguyen DTN; Caruana M; Lui G; Kelly H; Eckert LO; Santesso N; de Sanjose S; Swai EE; Rangaraj A; Owiredu MN; Gauvreau C; Demke O; Basu P; Arbyn M; Dalal S; Broutet N; Canfell K
Nat Med; 2023 Dec; 29(12):3059-3066. PubMed ID: 38087116
[TBL] [Abstract][Full Text] [Related]
20. HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis.
Mekuria SF; Timmermans S; Borgfeldt C; Jerkeman M; Johansson P; Linde DS
Syst Rev; 2023 Jun; 12(1):103. PubMed ID: 37349822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
